IDH2 and glioblastoma: Using whole-genome sequencing and mutational analysis, Parson and colleagues identified recurrent mutations in IDH1 and IDH2 at high frequencies in WHO grade II and III astrocytomas, oligodendrogliomas, oligoastrocytomas, as well as in glioblastomas [8,9].